Anti-BRAF mutation drug resistance enhances EGFR expression in melanomas [expression profiling]
Source: NCBI BioProject (ID PRJNA195561)
Source: NCBI BioProject (ID PRJNA195561)
0 0
Project name: Homo sapiens
Description: We treated melanoma cells with BRAF mutation with BRAF inhibitor and screened for BRAF inhibitor resistant cells. We extracted total mRNA from parental cells and resistant cell lines. We compared their expression by carried out Affymetrix Huex 1.0 ST expression array.Overall design: Two paired parental/derived cell lines were screened as per the summary above. BRAF inhibitory resistant cells had gene expression compared to the parental cell lines.
Data type: Transcriptome or Gene expression
Sample scope: Multiisolate
Relevance: Medical
Organization: John Wayne Cancer Institute
Literatures
- PMID: 25243790
Last updated: 2013-03-30